Hubei Hongyuan Pharmaceutical Technology Co Ltd (301246)

Currency in CNY
15.66
-0.05(-0.32%)
Closed·
301246 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
301246 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
15.5815.83
52 wk Range
10.5817.18
Key Statistics
Bid/Ask
15.67 / 15.66
Prev. Close
15.71
Open
15.71
Day's Range
15.58-15.83
52 wk Range
10.58-17.18
Volume
5.47M
Average Volume (3m)
7.89M
1-Year Change
19.37%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
301246 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Hubei Hongyuan Pharmaceutical Technology Co Ltd Company Profile

Hubei Hongyuan Pharmaceutical Technology Co., Ltd., together with its subsidiaries, engages in the production and sale of pharmaceutical products in China and internationally. It provides active pharmaceutical ingredients, such as metronidazole, benzoyl metronidazole, dimetrizole, and acyclovir; pharmaceutical intermediates, including imidazole, glyoxylic acid, 2-methyl imidazole, 2-methyl-5-nitroimidazole, sulfate, diacetyl guanine, guanine, and diacetylacyclovir; organic chemical raw materials comprising glyoxal, and oxalic acid; and new energy materials consisting of lithium hexafluorophosphate. The company was founded in 2002 and is headquartered in Huanggang, China.

Employees
2169
Market
China

Compare 301246 to Peers and Sector

Metrics to compare
301246
Peers
Sector
Relationship
P/E Ratio
213.3x31.2x−0.5x
PEG Ratio
−4.67−0.170.00
Price/Book
1.4x3.2x2.6x
Price / LTM Sales
3.5x4.8x3.3x
Upside (Analyst Target)
-15.0%43.4%
Fair Value Upside
Unlock4.8%7.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.07%
Dividend Yield
0.19%
Industry Median 1.51%
Annualised payout
0.03
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
0.02 / --
Revenue / Forecast
433.46M / --
EPS Revisions
Last 90 days

301246 Income Statement

FAQ

What Stock Exchange Does Hubei Hongyuan Pharmaceutical Trade On?

Hubei Hongyuan Pharmaceutical is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Hubei Hongyuan Pharmaceutical?

The stock symbol for Hubei Hongyuan Pharmaceutical is "301246."

What Is the Hubei Hongyuan Pharmaceutical Market Cap?

As of today, Hubei Hongyuan Pharmaceutical market cap is 6.21B.

What Is Hubei Hongyuan Pharmaceutical's Earnings Per Share (TTM)?

The Hubei Hongyuan Pharmaceutical EPS (TTM) is 0.07.

From a Technical Analysis Perspective, Is 301246 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Hubei Hongyuan Pharmaceutical Stock Split?

Hubei Hongyuan Pharmaceutical has split 0 times.

How Many Employees Does Hubei Hongyuan Pharmaceutical Have?

Hubei Hongyuan Pharmaceutical has 2169 employees.

What is the current trading status of Hubei Hongyuan Pharmaceutical (301246)?

As of 08 Aug 2025, Hubei Hongyuan Pharmaceutical (301246) is trading at a price of 15.66, with a previous close of 15.71. The stock has fluctuated within a day range of 15.58 to 15.83, while its 52-week range spans from 10.58 to 17.18.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.